Quadrant Capital Group LLC Grifols Sa Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Grifols Sa stock. As of the latest transaction made, Quadrant Capital Group LLC holds 6,712 shares of GRFS stock, worth $52,689. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,712

Previous 3,627 85.06%

Holding current value

$52,689

Previous $22,000 168.18%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$6.28 - $9.38 $19,373 - $28,937	3,085 Added 85.06%	6,712 $59,000
Q2 2024 Aug 12, 2024	SELL	$6.27 - $7.7 $12,239 - $15,030	-1,952 Reduced 34.99%	3,627 $22,000
Q1 2024 May 15, 2024	SELL	$5.47 - $11.38 $3,790 - $7,886	-693 Reduced 11.05%	5,579 $37,000
Q4 2023 Feb 08, 2024	BUY	$7.71 - $11.56 $462 - $693	60 Added 0.97%	6,272 $72,000
Q3 2023 Nov 14, 2023	BUY	$8.91 - $10.91 $418 - $512	47 Added 0.76%	6,212 $56,000
Q2 2023 Aug 09, 2023	BUY	$7.14 - $9.29 $2,241 - $2,917	314 Added 5.37%	6,165 $56,000
Q1 2023 May 11, 2023	BUY	$6.65 - $10.69 $6,596 - $10,604	992 Added 20.42%	5,851 $43,000
Q4 2022 Feb 10, 2023	BUY	$5.96 - $8.53 $10,149 - $14,526	1,703 Added 53.96%	4,859 $41,000
Q3 2022 Nov 10, 2022	SELL	$5.95 - $14.3 $56,203 - $135,077	-9,446 Reduced 74.96%	3,156 $19,000
Q2 2022 Aug 09, 2022	SELL	$10.6 - $13.28 $35,414 - $44,368	-3,341 Reduced 20.96%	12,602 $150,000
Q1 2022 May 06, 2022	BUY	$10.37 - $12.73 $42,454 - $52,116	4,094 Added 34.55%	15,943 $186,000
Q4 2021 Feb 01, 2022	BUY	$10.21 - $15.27 $84,344 - $126,145	8,261 Added 230.24%	11,849 $133,000
Q3 2021 Nov 12, 2021	SELL	$14.07 - $17.3 $20,725 - $25,482	-1,473 Reduced 29.1%	3,588 $52,000
Q2 2021 Aug 09, 2021	SELL	$16.62 - $18.94 $232 - $265	-14 Reduced 0.28%	5,061 $88,000
Q1 2021 May 12, 2021	SELL	$15.15 - $19.78 $10,498 - $13,707	-693 Reduced 12.01%	5,075 $88,000
Q4 2020 Feb 16, 2021	BUY	$16.86 - $19.67 $3,034 - $3,540	180 Added 3.22%	5,768 $106,000
Q3 2020 Nov 13, 2020	BUY	$15.4 - $20.16 $43,150 - $56,488	2,802 Added 100.57%	5,588 $97,000
Q2 2020 Aug 13, 2020	SELL	$18.24 - $21.45 $291,438 - $342,728	-15,978 Reduced 85.15%	2,786 $51,000
Q1 2020 May 15, 2020	BUY	$16.28 - $25.63 $5,844 - $9,201	359 Added 1.95%	18,764 $378,000
Q4 2019 Feb 03, 2020	SELL	$19.57 - $23.52 $40,138 - $48,239	-2,051 Reduced 10.03%	18,405 $422,000
Q3 2019 Oct 24, 2019	BUY	$19.85 - $22.76 $2,620 - $3,004	132 Added 0.65%	20,456 $400,000
Q2 2019 Jul 24, 2019	BUY	$17.59 - $21.1 $70,940 - $85,096	4,033 Added 24.76%	20,324 $422,000
Q1 2019 Apr 29, 2019	BUY	$18.01 - $20.11 $39,495 - $44,101	2,193 Added 15.56%	16,291 $318,000
Q4 2018 Jan 17, 2019	BUY	$17.44 - $21.53 $41,245 - $50,918	2,365 Added 20.16%	14,098 $252,000
Q3 2018 Oct 29, 2018	SELL	$19.97 - $21.96 $12,341 - $13,571	-618 Reduced 5.0%	11,733 $242,000
Q2 2018 Aug 09, 2018	BUY	$20.16 - $24.68 $4,717 - $5,775	234 Added 1.93%	12,351 $257,000
Q1 2018 May 10, 2018	BUY	$20.31 - $24.95 $10,520 - $12,924	518 Added 4.47%	12,117 $249,000
Q2 2017 Aug 15, 2017	BUY	N/A	11,599	11,599 $238,000

Others Institutions Holding GRFS

# of Institutions

164

Shares Held

140M

Call Options Held

288K

Put Options Held

389K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Grifols Sa Transaction History